- Filed
- Mar 27, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2022 · Dec 31, 2022 | 10.74M sh |
| Shares Diluted | Q2 2022 · Dec 31, 2021 | 55.51M sh |
| Capex | Q2 2022 · Dec 31, 2022 | $9.91M |
| Capex | Q2 2022 · Dec 31, 2021 | $390.3K |
| Operating Cash Flow | Q2 2022 · Dec 31, 2022 | −$3.2M |
| Operating Cash Flow | Q2 2022 · Dec 31, 2021 | −$3.82M |
| Cash And Equivalents | Q2 2022 · Dec 31, 2022 | $12.99M |
| Cash And Equivalents restated | Q2 2022 · Dec 31, 2021 | $21.16M |
| Stockholders Equity | Q2 2022 · Dec 31, 2022 | $103.83M |
| Stockholders Equity | Q2 2022 · Jun 30, 2022 | $109.19M |
| Current Liabilities | Q2 2022 · Dec 31, 2022 | $759.7K |
| Current Liabilities | Q2 2022 · Jun 30, 2022 | $1.12M |
| Total Liabilities | Q2 2022 · Dec 31, 2022 | $1.51M |
| Total Liabilities | Q2 2022 · Jun 30, 2022 | $1.14M |
| Current Assets | Q2 2022 · Dec 31, 2022 | $30.68M |
| Current Assets | Q2 2022 · Jun 30, 2022 | $46.73M |
| Total Assets | Q2 2022 · Dec 31, 2022 | $104.82M |
| Total Assets | Q2 2022 · Jun 30, 2022 | $114.57M |
| Eps Diluted | Q2 2022 · Dec 31, 2022 | $0.34 |
| Eps Diluted | Q2 2022 · Dec 31, 2021 | −$0.06 |
| Eps Basic | Q2 2022 · Dec 31, 2022 | −$0.36 |
| Eps Basic restated | Q2 2022 · Dec 31, 2021 | −$0.08 |
| Sga Expense | Q2 2022 · Dec 31, 2022 | $7.71M |
| Sga Expense | Q2 2022 · Dec 31, 2021 | $4.81M |
| Operating Income | Q2 2022 · Dec 31, 2022 | −$7.71M |
| Operating Income restated | Q2 2022 · Dec 31, 2021 | −$4.81M |
| Gross Profit | Q2 2022 · Dec 31, 2022 | $265.21K |
| Gross Profit | Q2 2022 · Dec 31, 2021 | $296.46K |
| Cost Of Revenue | Q2 2022 · Dec 31, 2022 | $367.98K |
| Cost Of Revenue | Q2 2022 · Dec 31, 2021 | $1.01M |